Diagnosis and Management of Autoimmune Hepatitis in Adults and Children: 2019 Practice Guidance and Guidelines From the American Association for the Study of Liver Diseases
University of Colorado Denver · NIHR Birmingham Liver Biomedical Research Unit · +10 more institutions
Abstract
Funding for the development of this Practice Guideline and Guidance was provided by the American Association for the Study of Liver Diseases. Potential conflict of interest: Dr. Mack consults for Albireo. Dr. Kerkar advises High Tide and received royalties from Elsevier. Dr. Manns consults for, is on the speakers' bureau for, and received grants from Falk. He consults for and received grants from Novartis. Dr. Vierling advises and received grants from CymaBay, Enanta, Genkyotex, Intercept, Lilly, Novartis, and TaiwanJ. He advises Arena, BioIncept, Blade, and GlaxoSmithKline and received grants from Allergan and NGM. What's New Since 2010 Guidelines? Histological features of NAFLD are present in 17%‐30% of…
Citation impact
- FWCI
- 43.77
- Percentile
- 100%
- References
- 671
Authors
10- CLCara L. MackCorresponding
University of Colorado Denver
- DADavid Adams
NIHR Birmingham Liver Biomedical Research Unit, University of Birmingham
- DNDavid N. Assis
Yale University
- NKNanda Kerkar
University of Rochester Medical Center, Golisano Children's Hospital
- MPMichael P. Manns
Medizinische Hochschule Hannover
Topics & keywords
- Medicine
- Autoimmune hepatitis
- Association (psychology)
- Hepatitis
- Family medicine
- Internal medicine
- Pediatrics
- Psychology
- Good health and well-being